Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
SOPHiA GENETICS
SOPH
$649M
| $64.2K | ﹤0.01% |
20,900
-1,000
| -5% | -$3.4K |
|
3352
Cognition Therapeutics
CGTX
$98.9M
| $63.9K | ﹤0.01% |
91,100
+2,400
| +3% | +$1.19K |
|
3353
Amtech Systems
ASYS
$280M
| $63.8K | ﹤0.01% |
+11,700
| New | +$66.4K |
|
3354
Yunhong Green CTI Ltd
YHGJ
$8.87M
| $63.5K | ﹤0.01% |
11,627
-550
| -5% | -$3.71K |
|
|
ZEPP
3355
Zepp Health
ZEPP
$78.6M
| $61.9K | ﹤0.01% |
23,824
-300
| -1% | -$947 |
|
|
NXDT
3356
NexPoint Diversified Real Estate Trust
NXDT
$261M
| $61.6K | ﹤0.01% |
10,098
-4,493
| -31% | -$26.4K |
|
3357
Grove Collaborative
GROV
$44M
| $60.5K | ﹤0.01% |
43,500
+11,400
| +36% | +$15.7K |
|
|
STRM
3358
DELISTED
Streamline Health Solutions
STRM
| $60.4K | ﹤0.01% |
16,057
+886
| +6% | +$2.5K |
|
|
MSC
3359
Studio City International Holdings
MSC
$333M
| $60.4K | ﹤0.01% |
10,685
-100
| -0.9% | -$656 |
|
3360
Socket Mobile
SCKT
$11.2M
| $60.1K | ﹤0.01% |
45,200
+19,700
| +77% | +$25.5K |
|
3361
AmpliTech
AMPG
$152M
| $59.6K | ﹤0.01% |
11,600
-11,347
| -49% | -$16K |
|
|
IPM
3362
Intelligent Protection Management Corp
IPM
$24.4M
| $59.3K | ﹤0.01% |
29,800
+400
| +1% | +$834 |
|
3363
Ribbon Communications
RBBN
$377M
| $58.7K | ﹤0.01% |
+14,100
| New | +$53.2K |
|
|
GCTS
3364
GCT Semiconductor Holding
GCTS
$197M
| $58.3K | ﹤0.01% |
+25,000
| New | +$63.1K |
|
|
FURY
3365
Fury Gold Mines
FURY
$116M
| $58.2K | ﹤0.01% |
157,178
-50,287
| -24% | -$21.3K |
|
3366
P3 Health Partners
PIII
$36.5M
| $58.1K | ﹤0.01% |
5,164
-4,526
| -47% | -$67.1K |
|
3367
Amesite
AMST
$7.01M
| $58K | ﹤0.01% |
+12,200
| New | +$37.4K |
|
3368
Smith Micro Software
SMSI
$16.2M
| $57.8K | ﹤0.01% |
8,828
+3,340
| +61% | +$15.4K |
|
|
STLN
3369
Starling Oncology, Inc. Common Stock
STLN
$638M
| $56.2K | ﹤0.01% |
182,000
+12,000
| +7% | +$3.11K |
|
3370
Stabilis Solutions
SLNG
$104M
| $56.2K | ﹤0.01% |
+10,500
| New | +$51.9K |
|
|
AACG
3371
ATA Creativity
AACG
$48M
| $56K | ﹤0.01% |
66,244
-1,900
| -3% | -$1.79K |
|
3372
Precipio
PRPO
$41.5M
| $56K | ﹤0.01% |
+10,100
| New | +$62.1K |
|
3373
Cheche Group
CCG
$42.6M
| $55.4K | ﹤0.01% |
+1,780
| New | +$52.4K |
|
3374
Dominari Holdings
DOMH
$70.3M
| $55.4K | ﹤0.01% |
56,326
+9,400
| +20% | +$15.4K |
|
|
MYSE
3375
Myseum.AI Inc
MYSE
$13.1M
| $55.4K | ﹤0.01% |
+31,100
| New | +$53.3K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.